| abstract |
5-chloro-2-[[(3,4-dimethoxy-2-pyridinyl) methyl]sulfinyl]-1H-benzimidazole and physiologically acceptable salts thereof as well as an intermediate, pharmaceutical compositions containing such compound as active ingredient, and the use of the compound in medicine, particularly for gastrointestinal disorders. The intermediate is 5-chloro-2-[[(3,4-dimethoxy-2-pyridinyl)-methyl]thio]-1H-benzimidazole. |